Wendy St. Peter, PharmD, explains how the new cardio-kidney-metabolic (CKM) syndrome guideline supports pharmacist-led medication management, staging tools, and de-prescribing.
Wendy L. St. Peter, PharmD, FCCP, FASN, FNKF
Advertisement
Wendy L. St. Peter, PharmD, FCCP, FASN, FNKF, is professor emerita at the University of Minnesota College of Pharmacy and a writing committee member for the new cardio-kidney-metabolic (CKM) syndrome guideline.
Articles by Wendy L. St. Peter, PharmD, FCCP, FASN, FNKF
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Functional Cure of Hepatitis B Infections Among Patients Coinfected With HIV
2
Why Stanford, Harvard, and Yale Are Betting on Psychedelics
3
Sustainable GLP-1 Coverage Requires Balancing Access, Cost, and Long-Term Value
4
FDA Expands Casgevy Approval to Children as Young as 2 Years With Sickle Cell Disease or Transfusion-Dependent β-Thalassemia
5